The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Cytokines as Endogenous Pyrogens
Abstract
Cytokines are pleiotropic molecules mediating several pathologic processes. Long before the discovery of cytokines as immune system growth factors or as bone marrow stimulants, investigators learned a great deal about cytokines when they studied them as the endogenous mediators of fever. The terms "granulocytic" or "endogenous pyrogen" were used to describe substances with the biologic property of fever induction. Today, we recognize that pyrogenicity is a fundamental biologic property of several cytokines and hence the clinically recognizeable property of fever links host perturbations during disease with fundamental perturbations in cell biology. In this review, the discoveries made on endogenous pyrogens are revisited, with insights into the importance of the earlier work to the present-day understanding of cytokines in health and in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Preliminary report: effects of interleukin-1 on platelet counts
Tewari, A., Starnes, H. F., & Buhles, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)92206-w · Cited by 159
RetractedDustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Self-citationEndres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationBevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationSchindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
Gery, I., Gershon, R. K., & Waksman, B. H. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.1.128 · Cited by 907
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Self-citationCloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y.-C. E., Collier, K., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Stanford, G. G., van der Meer, J. W. M., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.1.79 · Cited by 751
Self-citationPOTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
Gery, I., & Waksman, B. H. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.1.143 · Cited by 732
Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.914 · Cited by 669
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
van der Poll, T., Büller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Self-citationLibby, P., Ordovás, J. M., Auger, K. R., Robbins, A. H., Birinyi, L. K., & Dinarello, C. A. (1986) · PubMed Central · Cited by 494
Self-citationFisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A., & Goeddel, D. V. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2492 · Cited by 485
CORRELATION OF PLASMA INTERLEUKIN 1 LEVELS WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Eastgate, J., Wood, N., Di Giovine, F., Symons, J., Grinlinton, F., & Duff, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90185-7 · Cited by 484
Cloning and expression of murine IL-12
Schoenhaut, D. S., Chua, A. O., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., McComas, W., Familletti, P. C., Gately, M. K., & Gubler, U. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3433 · Cited by 470
SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES
Nijsten, M. W. N., De Groot, E. R., Ten Duis, H. J., Klasen, H. J., Hack, C. E., & Aarden, L. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91413-9 · Cited by 458
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Soluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Atkins, E. (1960) · Physiological Reviews · doi:10.1152/physrev.1960.40.3.580 · Cited by 387
Multiple biological activities of human recombinant interleukin 1.
Dinarello, C. A., Cannon, J. G., Mier, J. W., Bernheim, H. A., LoPreste, G., Lynn, D. L., Love, R. N., Webb, A. C., Auron, P. E., & Reuben, R. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112495 · Cited by 368
Self-citationProstacyclin Synthesis Induced in Vascular Cells by Interleukin-1
Rossi, V., Breviario, F., Ghezzi, P., Dejana, E., & Mantovani, A. (1985) · Science · doi:10.1126/science.2409598 · Cited by 360
Clinical effects and toxicity of interleukin-2 in patients with cancer
Lotze, M. T., Matory, Y. L., Rayner, A. A., Ettinghausen, S. E., Vetto, J. T., Seipp, C. A., & Rosenberg, S. A. (1986) · Cancer · doi:10.1002/1097-0142(19861215)58:12<2764::aid-cncr2820581235>3.0.co;2-z · Cited by 355
Bachwich, P. R., Chensue, S. W., Larrick, J. W., & Kunkel, S. L. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90881-8 · Cited by 337
Human leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Self-citationInterleukin 6 (IL-6) in serum and urine of renal transplant recipients.
van Oers, M. H. J., Heyden, A., & Aarden, L. A. (1988) · PubMed · Cited by 267
STUDIES ON THE PATHOGENESIS OF FEVER
Bennett, I. L., Beeson, P. B., & Roberts, W. T. T. A. O. E. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.5.493 · Cited by 263
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
Libby, P., Ordovas, J. M., Birinyi, L. K., Auger, K. R., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112732 · Cited by 258
Self-citationMurphy, P. A., Simon, P. L., & Willoughby, W. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.5.2498 · Cited by 257
Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1
Van Damme, J., De Ley, M., Opdenakker, G., Billiau, A., De Somer, P., & Beeumen, J. V. (1985) · Nature · doi:10.1038/314266a0 · Cited by 236
DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS
Dinarello, C. A., Goldin, N. P., & Wolff, S. M. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.6.1369 · Cited by 229
Self-citationMechanisms of fever induced by recombinant human interferon.
Dinarello, C. A., Bernheim, H. A., Duff, G. W., Le, H. V., Nagabhushan, T. L., Hamilton, N. C., & Coceani, F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111508 · Cited by 226
Self-citationSztein, M. B., Vogel, S. N., Sipe, J. D., Murphy, P. A., Mizel, S. B., Oppenheim, J. J., & Rosenstreich, D. L. (1981) · Cellular Immunology · doi:10.1016/0008-8749(81)90037-x · Cited by 221
Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs
Blatteis, C. M., Bealer, S. L., Hunter, W. S., Llanos, J.-Q., Ahokas, R. A., & Mashburn, T. A. (1983) · Brain Research Bulletin · doi:10.1016/0361-9230(83)90124-7 · Cited by 213
Mier, J. W., Vachino, G., van der Meer, J. W. M., Numerof, R. P., Adams, S., Cannon, J. G., Bernheim, H. A., Atkins, M. B., Parkinson, D. R., & Dinarello, C. A. (1988) · Journal of Clinical Immunology · doi:10.1007/bf00916947 · Cited by 212
Self-citationHuman large granular lymphocytes are potent producers of interleukin-1
Scala, G., Allavena, P., Djeu, J. Y., et al. (1984) · Nature · doi:10.1038/309056a0 · Cited by 209
Saklatvala, J., Sarsfield, S. J., & Townsend, Y. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.4.1208 · Cited by 193
Scala, G., Kuang, Y. D., Hall, R. E., Muchmore, A. V., & Oppenheim, J. J. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.6.1637 · Cited by 186
Production of interleukin-1 by bone marrow myeloma cells
Cozzolino, F., Torcia, M., Aldinucci, D., Rubartelli, A., Miliani, A., Shaw, A., Lansdorp, P., & Di Guglielmo, R. (1989) · Blood · doi:10.1182/blood.v74.1.380.380 · Cited by 185
Rosenwasser, L. J., Dinarello, C. A., & Rosenthal, A. S. (1979) · The Journal of experimental medicine · doi:10.1084/jem.150.3.709 · Cited by 183
Self-citationDinarello, C. A., Cannon, J. G., Mancilla, J., Bishai, I., Lees, J., & Coceani, F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90622-3 · Cited by 164
Self-citationLonnemann, G., Endres, S., Meer, J. W. M. V. D., Cannon, J. G., Koch, K. M., & Dinarello, C. A. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190903 · Cited by 163
Self-citationSmith, J. W., Urba, W. J., Curti, B. D., Elwood, L. J., Steis, R. G., Janik, J. E., Sharfman, W. H., Miller, L. L., Fenton, R. G., & Conlon, K. C. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1141 · Cited by 162
Fantuzzi, G., & Dinarello, C. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.489 · Cited by 156
Self-citationStitt, J. T. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015872 · Cited by 153
IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma.
Ghezzi, P., & Dinarello, C. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4238 · Cited by 151
Self-citationCrown, J. P., Jakubowski, A. A., Kemeny, N. E., Gordon, M. S., Gasparetto, C., Wong, G. G., Sheridan, C., Toner, G. C., Meisenberg, B., & Botet, J. F. (1991) · Blood · doi:10.1182/blood.v78.6.1420.1420 · Cited by 142
Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease.
Atkins, M. B., Gould, J. A., Allegretta, M., Li, J. J., Dempsey, R. A., Rudders, R. A., Parkinson, D. R., Reichlin, S., & Mier, J. W. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.9.1380 · Cited by 142
The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin
Smith, J. W., Longo, D. L., Alvord, W. G., Janik, J. E., Sharfman, W. H., Gause, B. L., Curti, B. D., Creekmore, S. P., Holmlund, J., Fenton, R. G., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303183281103 · Cited by 138
Rambaldi, A., Torcia, M., Bettoni, S., Vannier, E., Barbui, T., Shaw, A., Dinarello, C., & Cozzolino, F. (1991) · Blood · doi:10.1182/blood.v78.12.3248.3248 · Cited by 129
Self-citationSchindler, R., Ghezzi, P., & Dinarello, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2216 · Cited by 128
Self-citationCannon, J. G., van der Meer, J. W., Kwiatkowski, D. P., Endres, S., Lonnemann, G., Burke, J. F., & Dinarello, C. A. (1988) · PubMed · Cited by 122
Self-citationKnowledge and beliefs about cancer in a socioeconomically disadvantaged population
Loehrer, P. J., Greger, H. A., Weinberger, M., Musick, B. S., Miller, M. E., Nichols, C. R., Bryan, J., Higgs, D., & Brock, D. (1991) · Cancer · doi:10.1002/1097-0142(19911001)68:7<1520::aid-cncr2820680710>3.0.co;2-2 · Cited by 112
Milton, A. S. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68569-9 · Cited by 107
Atkins, E. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/149.3.339 · Cited by 102
RELEASE OF AN ENDOGENOUS PYROGEN IN VITRO FROM RABBIT MONONUCLEAR CELLS
Atkins, E., Bodel, P. T., & Francis, L. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.2.357 · Cited by 99
Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci.
Hanson, D. F., Murphy, P. A., & Windle, B. E. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.151.6.1360 · Cited by 84
Killing of Fabric-Associated Bacteria in Hospital Laundry by Low-Temperature Washing
Blaser, M. J., Smith, P. F., Cody, H. J., Wang, W.-L. L., & LaForce, F. M. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/149.1.48 · Cited by 78
Comparison of Leukocytic Pyrogen and Leukocytic Endogenous Mediator
Merriman, C. R., Pulliam, L. A., & Kampschmidt, R. F. (1977) · Experimental Biology and Medicine · doi:10.3181/00379727-154-39642 · Cited by 78
STUDIES ON THE PATHOGENESIS OF FEVER
Hahn, H. H., Char, D. C., Postel, W. B., & Wood, W. B. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.2.385 · Cited by 74
Release of Endogenous Pyrogen by Human Monocytes
Bodel, P. T., & Atkins, E. (1967) · New England Journal of Medicine · doi:10.1056/nejm196705042761803 · Cited by 74
Further purification of rabbit leukocyte pyrogen.
Pa, M., Chesney, P. J., & Wb, W. (1974) · PubMed · Cited by 68
HUMAN INTERLEUKIN 1: PURIFICATION AND PROPERTIES
Lachman, L. B. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-406080-7.50029-1 · Cited by 66
Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat
Coceani, F., Bishai, I., Dinarello, C. A., & Fitzpatrick, F. A. (1983) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1983.244.6.r785 · Cited by 65
Self-citationSchindler, R., & Dinarello, C. A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90199-3 · Cited by 63
Self-citationExpression of mRNA Homologous to Interleukin 1 in Human Epidermal Cells
Bell, T. V., Harley, C. B., Stetsko, D. K., & Sauder, D. N. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469041 · Cited by 62
Ciliary neurotrophic factor is an endogenous pyrogen.
Shapiro, L., Zhang, X., Rupp, R. G., Wolff, S. M., & Dinarello, C. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8614 · Cited by 57
Self-citationSTUDIES ON THE MECHANISM OF FEVER ACCOMPANYING DELAYED HYPERSENSITIVITY
Atkins, E., Feldman, J. D., Francis, L., et al. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.5.1113 · Cited by 50
Dinarello, C. A., Bernheim, H. A., Cannon, J. G., LoPreste, G., Warner, S. J. C., Webb, A. C., & Auron, P. E. (1985) · Lara D. Veeken · doi:10.1093/rheumatology/xxiv.suppl_1.59 · Cited by 50
Self-citationHanson, D. F., & Murphy, P. A. (1984) · Infection and Immunity · doi:10.1128/iai.45.2.483-490.1984 · Cited by 45
Rosenwasser, L. J., & Rosenthal, A. S. (1978) · PubMed · Cited by 42
Biologic Properties of Epidermal Cell Thymocyte-Activating Factor (ETAF)
Sauder, D. N. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276378 · Cited by 40
Interleukin-1: Biological Effects in Human Hematopoiesis
Crown, J., Jakubowski, A. A., & Gabrilove, J. L. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309145750 · Cited by 38
Bunning, R. A. D., Russell, R. G. G., & Damme, J. V. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90988-y · Cited by 38
Isolation and Characterization of Interleukin-1 From Bovine Polymorphonuclear Leukocytes
Canning, P. C., & Neill, J. D. (1989) · Journal of Leukocyte Biology · doi:10.1002/jlb.45.1.21 · Cited by 29
Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
Kurzrock, R., Quesada, J. R., Rosenblum, M. G., et al. (1986) · PubMed · Cited by 25
Tilg, H., Atkins, M. B., Dinarello, C. A., & Mier, J. W. (1995) · Cytokine · doi:10.1006/cyto.1995.0087 · Cited by 24
Self-citationPossible causes of fever after interferon administration.
Bocci, V. A. (1980) · PubMed · Cited by 22
TOLERABILITY OF PURE FIBROBLAST INTERFERON IN MAN
Billiau, A., Heine, J. W., Damme, J. V., Heremans, H., & Somer, P. D. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb20637.x · Cited by 15
Dascombe, M. J. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68569-9_9 · Cited by 6
Cited by
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa
Dantzer, R. (2018) · Physiological Reviews · doi:10.1152/physrev.00039.2016 · Cited by 1,073
The who's who of T ‐cell differentiation: Human memory T ‐cell subsets
Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M., & Lugli, E. (2013) · European Journal of Immunology · doi:10.1002/eji.201343751 · Cited by 817
The phagocytes: neutrophils and monocytes
Dale, D. C., Boxer, L., & Liles, W. C. (2008) · Blood · doi:10.1182/blood-2007-12-077917 · Cited by 740
Conjugated linoleic acids: are they beneficial or detrimental to health?
Wahle, K. W. J., Heys, S. D., & Rotondo, D. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.08.002 · Cited by 504
Metadata
- Authors
- Dinarello, C. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-03
- Volume
- 179
- Issue
- s2
- Pages
- S294-S304
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2141498118
- Cited by
- 387
- References
- 90
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.